MEMOGAIN Trademark

Trademark Overview

On Tuesday, June 27, 2017, a trademark application was filed for MEMOGAIN with the United States Patent and Trademark Office. The USPTO has given the MEMOGAIN trademark a serial number of 87507548. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 21, 2022. This trademark is owned by Neurodyn Life Sciences Inc.. The MEMOGAIN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, veterinary and sanitary preparations for treating central nervous system deficits; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of Alzheimer's disease, for the treatment of other dementias, Parkinson's disease, nootropics, schizophrenia preparations and other psychotropics, anti-depressives, geriatric preparations, acetylcholinesterase inhibitors, cholinergic enhancers, cholinomimetics

Pharmaceutical research and development services
memogain

General Information

Serial Number87507548
Word MarkMEMOGAIN
Filing DateTuesday, June 27, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2018

Trademark Statements

Goods and ServicesPharmaceutical, veterinary and sanitary preparations for treating central nervous system deficits; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of Alzheimer's disease, for the treatment of other dementias, Parkinson's disease, nootropics, schizophrenia preparations and other psychotropics, anti-depressives, geriatric preparations, acetylcholinesterase inhibitors, cholinergic enhancers, cholinomimetics
Goods and ServicesPharmaceutical research and development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 5, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 5, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeurodyn Life Sciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCharlottetown C1A4P3
CA
Party NameNeurodyn Life Sciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCharlottetown C1A4P3
CA

Trademark Events

Event DateEvent Description
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021EXTENSION 5 GRANTED
Thursday, June 17, 2021EXTENSION 5 FILED
Thursday, June 17, 2021TEAS EXTENSION RECEIVED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2020EXTENSION 4 GRANTED
Monday, December 14, 2020EXTENSION 4 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020EXTENSION 3 GRANTED
Tuesday, July 14, 2020EXTENSION 3 FILED
Tuesday, July 14, 2020TEAS EXTENSION RECEIVED
Thursday, January 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 8, 2020EXTENSION 2 GRANTED
Monday, December 30, 2019EXTENSION 2 FILED
Wednesday, January 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 30, 2019TEAS EXTENSION RECEIVED
Thursday, July 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2019EXTENSION 1 GRANTED
Tuesday, July 9, 2019EXTENSION 1 FILED
Tuesday, July 9, 2019TEAS EXTENSION RECEIVED
Thursday, February 7, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 23, 2019CORRECTED NOA E-MAILED
Tuesday, January 15, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 12, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 10, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, October 10, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 10, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, October 10, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 25, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 25, 2018NON-FINAL ACTION E-MAILED
Wednesday, April 25, 2018NON-FINAL ACTION WRITTEN
Saturday, April 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 19, 2018ASSIGNED TO LIE
Wednesday, April 11, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 9, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 9, 2018LETTER OF SUSPENSION E-MAILED
Monday, April 9, 2018SUSPENSION LETTER WRITTEN
Friday, March 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 15, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2017NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2017NON-FINAL ACTION WRITTEN
Sunday, September 24, 2017ASSIGNED TO EXAMINER
Wednesday, July 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 30, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

memogain preparations pharmaceutical treatment system disease nervous other treating central acetylcholinesterase